Evidence map›Paper›PMID 39627236›Full record

ArticleHuman genome variation2024

Neonatal myoclonus in Bryant-Li-Bhoj syndrome associated with a novel H3F3A variant.

Moemi Hojo, Noriko Soma, Kei Yamada, Yu Kobayashi, Masaki Miura, Hitomi Fujii, Hiromi Nyuzuki, Yosuke Nishio, Taichi Oso, Tomoo Ogi and 2 more

Abstract read
In one paragraph

Article in Human genome variation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Moemi HojoDepartment of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Japan.
Noriko SomaDepartment of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Japan.
Kei YamadaDepartment of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Japan.
Yu KobayashiDepartment of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Japan.
Masaki MiuraDepartment of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Japan.
Hitomi FujiiDepartment of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Japan.
Hiromi NyuzukiCenter for Medical Genetics, Niigata University Medical and Dental Hospital, Niigata, Japan.ORCID http://orcid.org/0000-0003-1502-0875
Yosuke NishioDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Taichi OsoDepartment of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Nagoya, Japan.
Tomoo OgiDepartment of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Nagoya, Japan.
Takeshi IkeuchiCenter for Medical Genetics, Niigata University Medical and Dental Hospital, Niigata, Japan.ORCID http://orcid.org/0000-0001-8828-8085
Jun TohyamaDepartment of Child Neurology, National Hospital Organization Nishiniigata Chuo Hospital, Niigata, Japan. tohyama.jun.um@mail.hosp.go.jp.ORCID http://orcid.org/0000-0001-6468-901X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bryant-Li-Bhoj syndrome (BLBS; OMIM # 619720, 619721), caused by germline H3F3A and H3F3B variants encoding histone H3.3, is characterized by mild to severe developmental delay, intellectual disability, failure to thrive, muscle tone abnormalities, and dysmorphic facial features. Here, we present a Japanese patient with a novel heterozygous p.A48G variant in H3F3A, displaying previously unrecognized symptoms of neonatal myoclonus. This case helps broaden the phenotypic spectrum of BLBS.

Identifiers

PMID39627236
PMCPMC11614866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.